Pharmaceuticals
Data Reveals Impact of Ocular Adverse Events During Cancer Therapy
Study finds higher frequency of anterior segment problems and links certain ones, including neuro-ophthalmic and corneal issues, to reduced survival, highlighting the need for collaborative management strategies.
09/19/2024
Can You Spot these Drug-induced Ocular Side Effects?
Consider these four cases involving toxic optic neuropathy and maculopathy to learn more about the potential mishaps of systemic meds.
09/15/2024
Can You Spot these Drug-induced Ocular Side Effects?
Consider these four cases involving toxic optic neuropathy and maculopathy to learn more about the potential mishaps of systemic meds.
09/15/2024
MD Groups Respond to Study Linking GLP-1 Treatment to NAION
The American Academy of Ophthalmology and North American Neuro-Ophthalmology Society stress that more research is needed to determine whether the association is causal.
07/11/2024
Fluoroquinolone Use Not Linked to Increased Uveitis, Retinal Detachment Risk
Although an association with this antibiotic treatment cannot be completely ruled out, any absolute effect would be small.
05/31/2024
Have You Kept Up with the Recent 'New Drug' Deluge?
Optometrists have access to many new meds right now, with a flood of more on the way. Here’s a comprehensive review of what’s out now and what’s in the pipeline.
03/15/2024
Safe and Savvy Prescribing of Oral Pharmaceuticals
Two experts share their best “dos and don'ts” to help you confidently handle the most common scenarios across several different categories of medications.
03/15/2024
The Wild and Woolly World of Anti-VEGF in 2023
A once-simple treatment protocol has gotten more sophisticated—and complicated—by novel drug compounds, varied dosing regimens and sustained-release delivery methods. Here’s the current state of affairs.
09/15/2023
Innovations, Part Two
These products are making an impact in the eyecare world.
05/15/2023
Statin Use, Certain Ethnicities Linked to Late-Onset AMD
On the flip side, female sex, obesity and fluoxetine use were found to be associated with earlier development.
03/17/2023
Upcoming Events
December 5, 2024
Rethinking Dry Eye Disease: A Contemporary Approach to a Complex Condition
Location: Virtual
Presenters: Nate Lighthizer, OD, and Dagny Zhu, MD
Webinar: 9:00pm ET
Sponsored by Bausch + Lomb
December 6-7, 2024
December 7-8, 2024
Retina Update 2024
Location: Westin Carlsbad, Carlsbad, California
Program Chairs: Mohammad Rafieetary, OD, and Steven Ferrucci, OD
Earn up to 11 LIVE COPE credits (accreditation pending)
